DAPTOMYCIN Accord subst sèche 500 mg flac

7680672730028 CH-67273 J01XX09 08.01.9.

Reimbursement limitations:

DAPTOMYCINAC

Chez l'adulte dans le traitement des infections compliquées de la peau et des tissus mous …

DAPTOMYCIN Accord subst sèche 500 mg flac
DAPTOMYCIN Accord subst sèche 500 mg flac
DAPTOMYCIN Accord subst sèche 500 mg flac
1 / 3
google

Details

Product number
6727302
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: daptomycinum 500 mg, natrii hydroxidum corresp. natrium 12.8 mg, pro vitro.

Articles (1)

Daptomycin Accord 500 mg, Pulver zur Herstellung einer Infusions-/Injektionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/10/2023
Professional SmPC
Français
17/10/2023
Professional SmPC
Italien
17/10/2023

Detailed composition

Substance Quantity Type Category
PRC
500.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
12.8 MG Substance HBESI

Reimbursement information

Public price
CHF 131.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2020

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67273
Drug name
Daptomycin Accord, Pulver zur Herstellung einer Infusions-/Injektionslösung
Galenic form
PULP
ATC Code
J01XX09
Authorization status
Z
Dispensation category
A
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT number
08.01.9.
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
DAPTOMYCIN Accord subst sèche 500 mg flac
Description (DE)
DAPTOMYCIN Accord Trockensub 500 mg Durchstf
Market launch
13/02/2020
Narcotic (BTM)
No

Original drug

Cubicin, Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 104.90
View original

Other packaging sizes

DAPTOMYCIN Accord subst sèche 350 mg flac
1 DUR
View